Zecong Xiao

3.1k total citations · 2 hit papers
59 papers, 2.5k citations indexed

About

Zecong Xiao is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Zecong Xiao has authored 59 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Biomedical Engineering, 25 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Zecong Xiao's work include Nanoplatforms for cancer theranostics (24 papers), Immunotherapy and Immune Responses (14 papers) and Wound Healing and Treatments (8 papers). Zecong Xiao is often cited by papers focused on Nanoplatforms for cancer theranostics (24 papers), Immunotherapy and Immune Responses (14 papers) and Wound Healing and Treatments (8 papers). Zecong Xiao collaborates with scholars based in China, United States and Australia. Zecong Xiao's co-authors include Xintao Shuai, Jinsheng Huang, Jiang Wu, Jian Xiao, Yong Wang, Shisong Han, Chaochao He, Yongcheng An, Kangshun Zhu and Minzhao Lin and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Zecong Xiao

54 papers receiving 2.4k citations

Hit Papers

Harnessing the potential ... 2021 2026 2022 2024 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions
    2024 254 citations Kangshun Zhu, Ziqi Gan et al. profile →
  2. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy
    2021 182 citations Jinsheng Huang, Zecong Xiao et al. Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zecong Xiao China 27 1.1k 788 579 466 371 59 2.5k
Yu Fan China 38 1.7k 1.5× 1.6k 2.0× 943 1.6× 326 0.7× 502 1.4× 91 3.7k
Zujian Feng China 24 1.0k 0.9× 832 1.1× 340 0.6× 193 0.4× 582 1.6× 51 2.2k
Junjie Deng China 27 1.3k 1.2× 867 1.1× 624 1.1× 223 0.5× 116 0.3× 75 2.4k
Kun Shi China 31 2.2k 1.9× 1.3k 1.6× 769 1.3× 369 0.8× 147 0.4× 66 3.4k
Ke Li China 30 1.8k 1.6× 817 1.0× 803 1.4× 466 1.0× 164 0.4× 89 3.0k
Huitong Ruan China 27 1.5k 1.3× 992 1.3× 1.0k 1.8× 457 1.0× 69 0.2× 45 2.8k
Santiago Correa United States 17 913 0.8× 688 0.9× 561 1.0× 228 0.5× 73 0.2× 28 2.1k
Libo Jiang China 29 1.1k 1.0× 636 0.8× 613 1.1× 116 0.2× 188 0.5× 81 2.7k
Qingfei Zhang China 27 913 0.8× 646 0.8× 465 0.8× 101 0.2× 199 0.5× 68 2.2k
Richard A. Gemeinhart United States 29 988 0.9× 1.2k 1.5× 1.0k 1.8× 150 0.3× 107 0.3× 60 3.3k

Countries citing papers authored by Zecong Xiao

Since Specialization
Citations

This map shows the geographic impact of Zecong Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zecong Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zecong Xiao more than expected).

Fields of papers citing papers by Zecong Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zecong Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zecong Xiao. The network helps show where Zecong Xiao may publish in the future.

Co-authorship network of co-authors of Zecong Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Zecong Xiao. A scholar is included among the top collaborators of Zecong Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zecong Xiao. Zecong Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Bihui, Manting Liu, Zecong Xiao, et al.. (2025). CV1-secreting sCAR-T cells potentiate the abscopal effect of microwave ablation in heterogeneous tumors. Cell Reports Medicine. 6(2). 101965–101965. 1 indexed citations
2.
Deng, Shaohui, Lijun Hu, Zecong Xiao, et al.. (2025). A PD‐L1 siRNA‐Loaded Boron Nanoparticle for Targeted Cancer Radiotherapy and Immunotherapy. Advanced Materials. 37(13). e2419418–e2419418. 14 indexed citations
3.
4.
Wang, Jiachen, et al.. (2025). A dissolvable microneedle platform for the delivery of tumor-derived total RNA nanovaccines for enhanced tumor immunotherapy. Acta Biomaterialia. 199. 120–131. 3 indexed citations
5.
Huang, Jing, Shuiwang Duan, Minzhao Lin, et al.. (2025). αPD-1-conjugated acid-cleavable nanodrugs overcomes cellular immunotherapy barriers in pancreatic tumors. Nature Communications. 17(1). 562–562.
6.
Cai, Yujun, Gengjia Chen, Minzhao Lin, et al.. (2024). Twins‐like nanodrugs synchronously transport in blood and coalesce inside tumors for sensitive ultrasound imaging and triggerable penetrative drug delivery. SHILAP Revista de lepidopterología. 5(3). 14 indexed citations
7.
Zheng, Xinyao, Shaohui Deng, Yuan Li, et al.. (2024). Targeting m6A demethylase FTO to heal diabetic wounds with ROS-scavenging nanocolloidal hydrogels. Biomaterials. 317. 123065–123065. 8 indexed citations
8.
He, Xiaofei, Yuan Peng, Sicong Huang, et al.. (2024). Blood Brain Barrier‐Crossing Delivery of Felodipine Nanodrug Ameliorates Anxiety‐Like Behavior and Cognitive Impairment in Alzheimer's Disease. Advanced Science. 11(34). e2401731–e2401731. 19 indexed citations
9.
10.
Chen, Gengjia, Liteng Lin, Bo Li, et al.. (2024). Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy. Biomaterials. 309. 122626–122626. 13 indexed citations
11.
12.
Wang, Xiaobin, Qiaoyun Zhang, Jingwen Zhou, et al.. (2023). T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 11(2). e006493–e006493. 17 indexed citations
13.
Chen, Ye, Weiguo Cai, Mingyue Cai, et al.. (2023). Intratumoral Lactate Depletion Based on Injectable Nanoparticles−Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence. Advanced Healthcare Materials. 13(6). e2303031–e2303031. 17 indexed citations
14.
Li, Bo, Gengjia Chen, Mingyue Cai, et al.. (2023). Anchoring Microbubbles on Cerebrovascular Endothelium as a New Strategy Enabling Low‐Energy Ultrasound‐Assisted Delivery of Varisized Agents Across Blood‐Brain Barrier. Advanced Science. 10(33). e2302134–e2302134. 15 indexed citations
15.
Lin, Minzhao, et al.. (2023). Nanodrug regulates ROS homeostasisviaenhancing fatty acid oxidation and inhibiting autophagy to overcome tumor drug resistance. Biomaterials Science. 11(21). 7179–7187. 6 indexed citations
16.
Xiao, Zecong, Yujun Cai, Xiaobin Wang, et al.. (2022). Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for effective immunotherapy against orthotopic pancreatic cancer. Nano Today. 44. 101490–101490. 25 indexed citations
17.
Su, Zhenwei, Zecong Xiao, Jinsheng Huang, et al.. (2021). Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy. ACS Applied Materials & Interfaces. 13(11). 12845–12856. 47 indexed citations
18.
Yu, Zhaolong, Zecong Xiao, Xintao Shuai, & Jiwei Tian. (2020). Local delivery of sunitinib and Ce6 via redox-responsive zwitterionic hydrogels effectively prevents osteosarcoma recurrence. Journal of Materials Chemistry B. 8(30). 6418–6428. 36 indexed citations
19.
Wu, Jiang, Zecong Xiao, Chaochao He, et al.. (2016). Protein diffusion characteristics in the hydrogels of poly(ethylene glycol) and zwitterionic poly(sulfobetaine methacrylate) (pSBMA). Acta Biomaterialia. 40. 172–181. 20 indexed citations
20.
Wu, Jiang, Yi Li, Chaochao He, et al.. (2016). Novel H2S Releasing Nanofibrous Coating for In Vivo Dermal Wound Regeneration. ACS Applied Materials & Interfaces. 8(41). 27474–27481. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Fan Breakdown of academic impact, for papers by Zujian Feng Breakdown of academic impact, for papers by Junjie Deng Breakdown of academic impact, for papers by Kun Shi Breakdown of academic impact, for papers by Ke Li Breakdown of academic impact, for papers by Huitong Ruan Breakdown of academic impact, for papers by Santiago Correa Breakdown of academic impact, for papers by Libo Jiang Breakdown of academic impact, for papers by Qingfei Zhang Breakdown of academic impact, for papers by Richard A. Gemeinhart
Rankless by CCL
2026